$16.40
0.09[0.55%]
At close: Apr 26
$16.40
0[0.00%]
After Hours: 7:10PM EDT
ACADIA Pharmaceuticals
(NASDAQ:ACAD)ACADIA Pharmaceuticals Stock (NASDAQ:ACAD), Guidance and Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/27/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $1.01B | $965.09M | Get Alert |
| 05/08/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $556.45M | Get Alert |
| 02/27/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $569.16M | Get Alert |
| 11/02/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $520.00M | $530.69M | Get Alert |
| 08/08/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $540.00M | $531.12M | Get Alert |
| 05/04/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $540.68M | Get Alert |
| 02/28/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $564.20M | Get Alert |
| 11/08/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $500.00M | $490.42M | Get Alert |
| 08/04/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $515.00M | $521.79M | Get Alert |
| 05/05/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $510.00M | $550.00M | $535.93M | Get Alert |
| 11/04/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $430.00M | $450.00M | $443.75M | Get Alert |
| 08/05/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $430.00M | $450.00M | $437.26M | Get Alert |
| 05/07/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $420.00M | $450.00M | $449.80M | Get Alert |
| 02/26/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $440.00M | $470.00M | $444.04M | Get Alert |
| 10/30/2019 | ACAD | ACADIA Pharmaceuticals | FY | 2019 | — | — | — | $330.00M | $340.00M | $326.78M | Get Alert |
| 10/02/2019 | ACAD | ACADIA Pharmaceuticals | FY | 2019 | — | — | — | $320.00M | $330.00M | $326.72M | Get Alert |
| 07/31/2019 | ACAD | ACADIA Pharmaceuticals | FY | 2019 | — | — | — | $320.00M | $330.00M | $292.81M | Get Alert |
FAQ
What is the most recent guidance for ACADIA Pharmaceuticals (ACAD)?
There have been no specific sales or earnings guidance reported for ACADIA Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.